The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin.

The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx face growing criticism over ...

Texas is the latest state to join the legal fight with drug manufacturers and pharmacy benefit managers over the cost of ...

Texas is suing insulin manufacturers and PBMs, including Eli Lilly and CVS Pharmacy, alleging a scheme to hike insulin prices ...

The Federal Trade Commission staff is criticizing pharmaceutical benefit managers, which negotiate drug discounts. But ...

A bill aimed at reining in the outsize power of pharmacy benefit managers made it to the governor’s desk for naught.

This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements ...

Texas Attorney General Ken Paxton alleges several major manufacturers and pharmacy benefit managers have driven the costs of ...

CVS (CVS) and Cigna (CI) attacked in the U.S. Congress over a new anticompetitive practice of co-manufacturing run by their ...

The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing them of ...

The Federal Trade Commission's new lawsuit against big pharmaceutical "middlemen" threatens to disrupt a system that has been ...

Blue Shield of California struck an unusual deal to buy a lower-cost version of Humira directly from a manufacturer, ...